Research
Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.
Latest stories
Medical Innovation
September 21, 2026
Research
September 15, 2026
Research
September 14, 2026
Research
September 10, 2026
Neurosciences
September 9, 2026
Research
September 2, 2026
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community